title: Clinical COPD phenotypes: a novel approach using principal component and cluster analyses.
abstract: Classification of chronic obstructive pulmonary disease (COPD) is usually based on the severity of airflow limitation, which may not reflect phenotypic heterogeneity. Here, we sought to identify COPD phenotypes using multiple clinical variables. COPD subjects recruited in a French multicentre cohort were characterised using a standardised process. Principal component analysis (PCA) was performed using eight variables selected for their relevance to COPD: age, cumulative smoking, forced expiratory volume in 1 s (FEV(1)) (% predicted), body mass index, exacerbations, dyspnoea (modified Medical Research Council scale), health status (St George's Respiratory Questionnaire) and depressive symptoms (hospital anxiety and depression scale). Patient classification was performed using cluster analysis based on PCA-transformed data. 322 COPD subjects were analysed: 77% were male; median (interquartile range) age was 65.0 (58.0-73.0) yrs; FEV(1) was 48.9 (34.1-66.3)% pred; and 21, 135, 107 and 59 subjects were classified in Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages 1, 2, 3 and 4, respectively. PCA showed that three independent components accounted for 61% of variance. PCA-based cluster analysis resulted in the classification of subjects into four clinical phenotypes that could not be identified using GOLD classification. Importantly, subjects with comparable airflow limitation (FEV(1)) belonged to different phenotypes and had marked differences in age, symptoms, comorbidities and predicted mortality. These analyses underscore the need for novel multidimensional COPD classification for improving patient care and quality of clinical trials.
authors.affiliation: Service de Pneumologie, Hôpital Cochin, Assistance Publique Hôpitaux de Paris, 27 rue du Faubourg St Jacques, 75679 Paris Cedex 14, France. pierre-regis.burgel@cch.aphp.fr
authors.forename: P-R
authors.initials: PR
authors.lastname: Burgel
authors.forename: J-L
authors.initials: JL
authors.lastname: Paillasseur
authors.forename: D
authors.initials: D
authors.lastname: Caillaud
authors.forename: I
authors.initials: I
authors.lastname: Tillie-Leblond
authors.forename: P
authors.initials: P
authors.lastname: Chanez
authors.forename: R
authors.initials: R
authors.lastname: Escamilla
authors.forename: I
authors.initials: I
authors.lastname: Court-Fortune
authors.forename: T
authors.initials: T
authors.lastname: Perez
authors.forename: P
authors.initials: P
authors.lastname: Carré
authors.forename: N
authors.initials: N
authors.lastname: Roche
mesh_terms: D000368:Aged; D016000:Cluster Analysis; D015897:Comorbidity; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D025341:Principal Component Analysis; D029424:Pulmonary Disease, Chronic Obstructive / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*; D015272:Pulmonary Medicine / Q000379:methods; D012107:Research Design